279 related articles for article (PubMed ID: 32301286)
1. Clinical characteristics and prognosis of pulmonary large cell carcinoma: A population-based retrospective study using SEER data.
Xiaochuan L; Jiangyong Y; Ping Z; Xiaonan W; Lin L
Thorac Cancer; 2020 Jun; 11(6):1522-1532. PubMed ID: 32301286
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy improves the prognosis of early stage resectable pulmonary large cell carcinoma: analysis of SEER data.
Hu X; Tai Q; Su B; Zhang L
Ann Palliat Med; 2020 Mar; 9(2):199-206. PubMed ID: 32156139
[TBL] [Abstract][Full Text] [Related]
3. The Clinical Characteristics and Treatments for Large Cell Carcinoma Patients Older than 65 Years Old: A Population-Based Study.
Yao A; Liang L; Rao H; Shen Y; Wang C; Xie S
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358648
[TBL] [Abstract][Full Text] [Related]
4. Progress in the Treatment and Outcomes for Early-Stage Non-Small Cell Lung Cancer.
Shin JY; Yoon JK; Marwaha G
Lung; 2018 Jun; 196(3):351-358. PubMed ID: 29550987
[TBL] [Abstract][Full Text] [Related]
5. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
[TBL] [Abstract][Full Text] [Related]
6. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
[No Abstract] [Full Text] [Related]
7. Lung Large Cell Neuroendocrine Carcinoma: An Analysis of Patients from the Surveillance, Epidemiology, and End-Results (SEER) Database.
Deng C; Wu SG; Tian Y
Med Sci Monit; 2019 May; 25():3636-3646. PubMed ID: 31095532
[TBL] [Abstract][Full Text] [Related]
8. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
[TBL] [Abstract][Full Text] [Related]
9. Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.
Kinslow CJ; May MS; Saqi A; Shu CA; Chaudhary KR; Wang TJC; Cheng SK
Clin Lung Cancer; 2020 Mar; 21(2):e99-e113. PubMed ID: 31601526
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of visceral pleural invasion in the stage pT
Zhang X; Xie J; Hu S; Peng W; Xu B; Li Y; Li C
Curr Probl Cancer; 2021 Feb; 45(1):100640. PubMed ID: 32828574
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R
J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
[TBL] [Abstract][Full Text] [Related]
12. The role of comorbidity in the management and prognosis in nonsmall cell lung cancer: a population-based study.
Nilsson J; Berglund A; Bergström S; Bergqvist M; Lambe M
Acta Oncol; 2017 Jul; 56(7):949-956. PubMed ID: 28486004
[TBL] [Abstract][Full Text] [Related]
13. Factors for incidence risk and prognosis of synchronous brain metastases in pulmonary large cell carcinoma patients: a population-based study.
Zheng X; Mu S; Wang L; Tao H; Huang D; Huang Z; Li X; Cui P; Li T; Liu Q; Hu Y
BMC Pulm Med; 2023 Jan; 23(1):12. PubMed ID: 36635639
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of age at diagnosis among young non-small cell lung cancer patients under 40 years old: a population-based study.
Liu M; Cai X; Yu W; Lv C; Fu X
Oncotarget; 2015 Dec; 6(42):44963-70. PubMed ID: 26517681
[TBL] [Abstract][Full Text] [Related]
15. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
16. Factors Associated With Treatment of Clinical Stage I Non-Small-cell Lung Cancer: A Population-based Analysis.
Berry MF; Canchola AJ; Gensheimer MF; Gomez SL; Cheng I
Clin Lung Cancer; 2018 Sep; 19(5):e745-e758. PubMed ID: 30149883
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of local thoracic surgery in patients with stage IV non-small-cell lung cancer: A SEER-based analysis.
Jia J; Guo B; Yang Z; Liu Y; Ga L; Xing G; Zhang S; Jin A; Ma R; Wang J
Eur J Cancer; 2021 Feb; 144():326-340. PubMed ID: 33388490
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary sarcomatoid carcinoma: an analysis of a rare cancer from the Surveillance, Epidemiology, and End Results database.
Rahouma M; Kamel M; Narula N; Nasar A; Harrison S; Lee B; Stiles B; Altorki NK; Port JL
Eur J Cardiothorac Surg; 2018 Apr; 53(4):828-834. PubMed ID: 29240878
[TBL] [Abstract][Full Text] [Related]
19. Incidence and survival analyses for occult lung cancer between 2004 and 2015: a population-based study.
Wu LL; Li CW; Lin WK; Qiu LH; Xie D
BMC Cancer; 2021 Sep; 21(1):1009. PubMed ID: 34496775
[TBL] [Abstract][Full Text] [Related]
20. Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis.
Subramanian J; Morgensztern D; Goodgame B; Baggstrom MQ; Gao F; Piccirillo J; Govindan R
J Thorac Oncol; 2010 Jan; 5(1):23-8. PubMed ID: 19934774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
